“This preclinical work will help strengthen Emyria’s intellectual property relating to our synthetic cannabinoid platform. Importantly, this work will.
china stocks, China small caps, comment, analysis, financial news, news, mining news, oil and gas news on small cap companies on the Hong Kong, Shenzhen, Shanghai, Australian Stock Exchange, Toronto Stock Exchange, NYSE, NASDAQ and London Stock Exchange and AIM markets in China, Australia, Canada and the UK.
Tryp has also entered into an agreement with Gad Consulting Services to collaborate on the preclinical studies
San Diego, California (Newsfile Corp. - August 10, 2021) - Tryp Therapeutics (CSE: TRYP)